Thursday, October 9, 2025
Home Blog Page 3

Nobel Prize in Chemistry 2025 winners announced: A look at their groundbreaking work | In Pics

0

Susumu Kitagawa, Richard Robson and Omar M Yaghi now joins a coveted list of 198 laureates such as Marie Curie for breakthrough work in Chemuistry.

By CNBCTV18.com October 8, 2025, 4:50:30 PM IST (Published)
2 Min Read

CNBCTV18 on Google

Image count1 / 6
CNBCTV18 on Google

Nobel Prize in Chemistry 2025  Winners | The Nobel Prize in Chemistry 2025 was awarded to Susumu Kitagawa, Richard Robson and Omar M Yaghi “for the development of metal-organic frameworks (MOF).” (Image: X/@NobelPrize)

Image count2 / 6
CNBCTV18 on Google

Discovering MOFs | Their research, done separately, led to building a special kind of molecular structure called a metal-organic framework (MOF). These MOFs hold remarkable potential in solving real-world problems. It can be applied for solutions to harvest water from desert air, capture carbon dioxide, store toxic gases or catalyse chemical reactions. (Image: Canva)

Image count3 / 6
CNBCTV18 on Google

About Susumu Kitagawa | Kitagawa is a professor at Kyoto University, where he completed most of his higher studies from bachelor’s through PhD. He was honoured with many awards, including the Chemical Society of Japan Award (2009), Thomson Reuters Citation Laureate (Chemistry) (2010), the Fellow of the UK Royal Society of Chemistry (2013), and the Kyoto Prefecture Culture Prize for Outstanding Contribution (2025), among others. (Image: Kyoto University)

Image count4 / 6
CNBCTV18 on Google

About Richard Robson | Robson is a professor at the University of Melbourne. He was a Fellow of the Australian Academy of Science (FAA) in the year 2000 and received the Burrows Award, RACI in 1998. (Image: University of Melbourne)

Image count5 / 6
CNBCTV18 on Google

About Omar Yaghi | Yaghi is a Professor of Chemistry at UC Berkeley. He received his PhD in Chemistry from the University of Illinois at Urbana-Champaign and was an NSF Postdoctoral Fellow at Harvard University. The scientist is also a member of the US National Academy of Sciences and the German National Academy of Sciences Leopoldina. The Royal Society of Chemistry Centenary Prize (2010), King Faisal International Prize in Science (2015), Albert Einstein World Award of Science (2017), and Balzan Prize (2024) are just a few of the many awards and honours Yaghi has earned. (Image: University of California)

Image count6 / 6
CNBCTV18 on Google

Nobel Prize in Chemistry History | Since 1901, the Royal Swedish Academy of Sciences has awarded 117 Nobel Prizes for exceptional work in Chemistry. A total of 198 individuals, including eight women, have received the prize so far. The youngest recipient is Frédéric Joliot, who won it at 35 years old in 1935, while the oldest is John B. Goodenough, who was 97 years old when he was awarded the prize in 2019.

Source link

Banking Attorney McKernan Confirmed to US Domestic Finance Job

0

Jonathan McKernan, an attorney who specialized in banking and consumer financial laws, has won US Senate confirmation to the top domestic finance job at the Treasury Department.

McKernan was first nominated by President Donald Trump to take the helm of the Consumer Financial Protection Bureau, but the administration shifted in May to tap him to become Treasury undersecretary for domestic finance. He had been working as an adviser at the Treasury, leading meetings with the Federal Reserve and other bank agencies.

“He will play an instrumental role in strengthening our economy by clawing back the government overreach and excess that defined previous administrations,” Treasury Secretary Scott Bessent said in a statement released by the department late Tuesday.

Among the key tasks for the Treasury’s head of domestic finance is overseeing debt-management and the smooth functioning of the $30 trillion Treasuries market.

McKernan is a former member of the Federal Deposit Insurance Corp.’s board of directors, and previously worked as an attorney in private practice on banking matters.

“I want to thank President Trump and Secretary Bessent for their confidence in me to further the economic agenda of this Administration as we look to accelerate this nation’s sustainable economic growth,” McKernan said.

McKernan is the third Senate-confirmed official now working at Treasury, including Bessent and the undersecretary for terrorism and financial intelligence, John Hurley. Michael Faulkender, who had held the position of deputy Treasury secretary since March, departed in August. Bessent has tapped Derek Theurer to perform the duties of the deputy Secretary in the meantime.

Related: Bessent Taps Theurer for Deputy Secretary Duties at Treasury

This article was generated from an automated news agency feed without modifications to text.

Source link

Star Forecaster Eyes 2024 Levels for Mexican Peso on Trade Pact

0

(ब्लूमबर्ग) – मुद्रा के शीर्ष भविष्यवक्ता के अनुसार, अमेरिका और कनाडा के साथ मेक्सिको की आगामी व्यापार वार्ता से पेसो – इस साल उभरते बाजार में शीर्ष प्रदर्शनकर्ता – को 2024 में आखिरी बार देखी गई ऊंची ऊंचाइयों तक पहुंचने में मदद मिल सकती है।

प्रेस्टीज इकोनॉमिक्स के अध्यक्ष जेसन शेंकर ने कहा, अगले साल होने वाले संयुक्त राज्य अमेरिका-मेक्सिको-कनाडा समझौते की समीक्षा से पहले “मेक्सिको के लिए बहुत सारी अच्छी बातें” हैं। एक ताज़ा समझौता निवेशकों के विश्वास को बढ़ा सकता है और मैक्सिकन निर्यात की मांग को बढ़ा सकता है, जो पेसो का समर्थन करता है।

अमेरिका के साथ व्यापार वार्ता के बारे में राष्ट्रपति क्लाउडिया शीनबाम की टिप्पणियों के बाद बुधवार को मुद्रा में उछाल आया।

शेंकर ने कहा कि एक सकारात्मक व्यापार समझौता अगले डेढ़ साल में पेसो को 17 डॉलर प्रति डॉलर तक पहुंचा सकता है। यह 7% से अधिक के लाभ का प्रतिनिधित्व करेगा, जो इसे 2024 के मध्य के बाद से नहीं देखे गए स्तर पर लाएगा। उनका मानना ​​है कि वर्ष के अंत में मुद्रा 18.35 पर समाप्त होगी, जो काफी हद तक वर्तमान विनिमय दर के अनुरूप है।

शेंकर प्रेस्टीज के पूर्वानुमानों की देखरेख करते हैं, जो पेसो के लिए सबसे अच्छा भविष्यवक्ता होने के अलावा ब्लूमबर्ग की एफएक्स पूर्वानुमानकर्ताओं की रैंकिंग में लगातार दूसरी तिमाही में शीर्ष पर है।

राष्ट्रपति डोनाल्ड ट्रम्प के व्यापार युद्ध में मेक्सिको की संभावनाओं के बीच आशावाद के बीच मुद्रा ने 2 अप्रैल से 10% की वृद्धि की है, जो उभरते बाजार के अधिकांश साथियों को पीछे छोड़ रही है। डॉयचे बैंक एजी के शोध के अनुसार, जुलाई तक अमेरिका को देश का निर्यात सालाना 8% बढ़ गया, और यूएसएमसीए की बदौलत इसे अन्य अमेरिकी व्यापार भागीदारों की तुलना में कम टैरिफ का सामना करना पड़ता है।

शेंकर के अनुसार पेसो को कम बेरोजगारी वाली मजबूत घरेलू अर्थव्यवस्था से भी मदद मिली है।

जबकि ट्रांसशिपमेंट को लेकर सवाल बने हुए हैं – जब माल को कम टैरिफ वाले देशों के माध्यम से फिर से भेजा जाता है – शेंकर ने कहा कि जब व्यापार समझौते पर फिर से बातचीत होती है तो “मेक्सिको एक बहुत बड़ा विजेता होने जा रहा है”।

उन्होंने कहा, पेसो अभी “कृत्रिम रूप से कमजोर है”। “हम एक होल्डिंग पैटर्न में हैं।”

इस तरह की और भी कहानियाँ उपलब्ध हैं ब्लूमबर्ग.कॉम

Source link

AstraZeneca secures approval to market cancer therapy Enhertu in India for new indication

0

Drug firm AstraZeneca Pharma India Limited on Friday (October 3) said it has received approval from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, to import, sell, and distribute trastuzumab deruxtecan 100mg/5mL vial lyophilised powder for concentrate for solution for infusion (brand name: Enhertu) for an additional indication.

Under this approval, Enhertu is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumours, who have received prior systemic treatment and have no satisfactory alternative treatment options.

The company stated that the approval paves the way for marketing of Enhertu in India for the specified additional indication, subject to receipt of other related statutory approvals, if any.

Also Read: AstraZeneca vows to spend $50 billion on US manufacturing, development

Fourth Quarter Results

AstraZeneca Pharma India posted a sharp 47.7% year-on-year jump in net profit to ₹58.2 crore for the fourth quarter ended March 2025, up from ₹39.4 crore a year earlier. The robust performance was underpinned by solid growth in revenue and a significant expansion in operating margin.

Revenue for the quarter rose 25.4% to ₹480.4 crore, compared with ₹383.2 crore in the same period last year, driven by continued demand across its key therapy areas and improved market penetration.

Earnings before interest, tax, depreciation and amortisation (EBITDA) surged 74.7% to ₹86.3 crore from ₹49.4 crore a year ago, reflecting better cost controls and favourable product mix. The company’s EBITDA margin expanded to 17.96%, up from 12.89% in the corresponding quarter last year.

Also Read: AstraZeneca Pharma India shares rise 8% after revenue, margin jump in Q4

Shares of Astrazeneca Pharma India Ltd ended at ₹9,320.00, up by ₹98.75, or 1.07%, on the BSE.

Source link

Fed minutes: Most officials supported further rate cuts as worries about jobs rose

0

Most members of the Federal Reserve’s interest-rate setting committee supported further reductions to its key interest rate this year, minutes from last month’s meeting, released Wednesday (October 8), showed.A majority of Fed officials felt that the risk that unemployment would rise had worsened since their previous meeting in July, while the risk of rising inflation “had either diminished or not increased,” the minutes said. As a result, the central bank decided at its September 16-17 meeting to reduce its key rate by a quarter-point, its first cut this year, to about 4.1%.

Rate cuts by the Fed can lower borrowing costs, over time, for things like mortgages, auto loans, and business loans, encouraging more spending, growth and hiring.

Also Read: Gold jumps ₹700 to fresh peak as Fed rate cut bets fuel safe-haven demand
Still, the minutes underscored the deep division on the 19-person committee between those who feel that the Fed’s short-term rate is too high and weighing on the economy, and those who point to persistent inflation that remains above the central bank’s 2% target as evidence that the Fed needs to be cautious about reducing rates.Only one official formally dissented from the quarter-point cut: Stephen Miran, who was appointed by President Donald Trump and was approved by the Senate just hours before the meeting began. He supported a larger, half-point cut instead.

But the minutes noted that “a few” policymakers said they could have supported keeping rates unchanged, or said that “there was merit” in such a step. The differences help explain Chair Jerome Powell’s statements during the news conference that followed the meeting: “There are no risk-free paths now. It’s not incredibly obvious what to do.”

Also Read: Jerome Powell signals Federal Reserve to move slowly on interest rate cuts

Miran said in remarks Tuesday that he thinks inflation will steadily decline back toward the Fed’s 2% target, despite Trump’s tariffs, and as a result, he doesn’t think the Fed’s rate needs to be nearly as high as it is. Rental costs are steadily declining and will bring down inflation, he said, while tariff revenue will reduce the government’s budget deficit and reduce longer-term interest rates, which gives the Fed more room to cut.

The minutes provide insight into how the Fed’s policymakers were thinking last month about inflation, interest rates, and hiring. Since then, however, the federal government shutdown has cut off the flow of economic data that the Fed relies on to inform its decisions. The September jobs report wasn’t issued as scheduled last Friday, and if the shutdown continues, it could also delay the release of the inflation report set for next Wednesday.

Source link

SEBI clears IHH Healthcare’s long-stalled 26.1% Fortis open offer after seven years

0

The long-delayed open offer by IHH Healthcare Berhad for a 26.1% stake in Fortis Healthcare has finally received the nod from India’s capital market regulator SEBI, nearly seven years after the Malaysian firm initially acquired a 31.1% stake in the Indian hospital chain, according to a regulatory filing submitted on Friday.SEBI, in its letter dated October 1, 2025, has granted approval to IHH to move forward with the open offer for Fortis Healthcare as well as its subsidiary Fortis Malar Hospitals, the Malaysian company stated in a filing to the Malaysian Stock Exchange. Fortis Healthcare also shared the update on the BSE platform.

IHH’s plan for the open offer had been stalled due to prolonged legal disputes, including at the Supreme Court, between Daiichi Sankyo and the former promoters of Fortis Healthcare, the Singh Brothers — Malvinder and Shivinder. The Japanese company had sought to recover ₹3,500 crore awarded by a Singapore arbitral tribunal in a case related to the acquisition of the erstwhile Ranbaxy.

In September 2022, IHH indicated that the Supreme Court ruling had cleared the path for the open offer, though the execution was contingent on SEBI’s approval.
The origins of the dispute trace back to 2018, when IHH Healthcare secured a ₹4,000-crore deal to acquire a 31.1% stake in Fortis Healthcare, outperforming rival bids, including one from the Manipal-TPG consortium. Following this, IHH had planned an open offer for an additional 26% stake in Fortis, scheduled to run from December 18, 2018, to January 1, 2019, involving a total consideration of ₹3,300 crore.However, in December 2018, the Supreme Court imposed a status quo on the sale of controlling stakes in Fortis Healthcare to IHH by the former Ranbaxy promoters, Malvinder and Shivinder Singh, following a plea from Daiichi Sankyo. This order effectively put the open offer on hold, delaying the transaction for several years.

Daiichi Sankyo had been pursuing enforcement of a foreign arbitral award issued in Singapore on April 29, 2016, amounting to ₹3,600 crore in its favour, against 20 respondents, including Malvinder Mohan Singh, Director of Oscar Investments Ltd and RHC Holding Pvt Ltd, and Shivinder Mohan Singh, Director of Oscar Investments Ltd.

The legal tussle had kept the former promoters of Fortis Healthcare entangled in court proceedings as Daiichi challenged the Fortis-IHH share acquisition, seeking recovery of the arbitration award, which had been a key hurdle delaying the completion of IHH’s open offer.

This approval by SEBI now clears the way for IHH to proceed with acquiring the additional 26.1% stake, concluding a protracted seven-year wait since the initial acquisition and legal battles surrounding the Fortis-IHH deal.

Fortis Healthcare is one of India’s leading private hospital chains, with a nationwide network of hospitals and a strong presence in specialty and multi-specialty care. IHH Healthcare Berhad, based in Malaysia, is a global healthcare provider with operations spanning Asia, including hospitals in India, Singapore, and Malaysia, focusing on expanding its footprint in the Indian healthcare sector.

Source link

Want To Know Your EPF Balance? Here’s How To Check It With Or Without UAN | Economy News

0

नई दिल्ली: कर्मचारी भविष्य निधि (ईपीएफ) वेतनभोगी व्यक्तियों के लिए एक महत्वपूर्ण सेवानिवृत्ति बचत योजना के रूप में कार्य करता है, जो उन्हें भविष्य के लिए वित्तीय सहायता प्रदान करता है। कर्मचारी और नियोक्ता दोनों हर महीने कर्मचारी के वेतन का 12 प्रतिशत इस फंड में योगदान करते हैं। अपनी बढ़ती बचत पर नज़र रखने के लिए, नियमित रूप से अपना ईपीएफ बैलेंस जांचना महत्वपूर्ण है। इसके लिए, आपको एक सक्रिय यूनिवर्सल अकाउंट नंबर (यूएएन) की आवश्यकता होगी, जो आपके वेतन पर्ची पर उल्लिखित एक अद्वितीय आईडी है जो आपके सभी पीएफ खातों को एक नंबर के तहत जोड़ता है।

आप आधिकारिक ईपीएफओ पोर्टल के माध्यम से आसानी से अपना ईपीएफ बैलेंस ऑनलाइन चेक कर सकते हैं। इसे करने का तरीका यहां बताया गया है:

चरण 1: आधिकारिक ईपीएफओ वेबसाइट पर जाएं –
चरण 2: “हमारी सेवाएं” अनुभाग पर जाएं और “कर्मचारियों के लिए” पर क्लिक करें।
चरण 3: “सदस्य पासबुक” चुनें और अपने यूनिवर्सल अकाउंट नंबर (यूएएन) और पासवर्ड के साथ लॉग इन करें।
चरण 4: एक बार लॉग इन करने के बाद, आप अपना अपडेटेड पीएफ बैलेंस और लेनदेन विवरण देख पाएंगे।

ज़ी न्यूज़ को पसंदीदा स्रोत के रूप में जोड़ें

यदि आप ईपीएफओ वेबसाइट का उपयोग नहीं करना चाहते हैं, तो आपके पीएफ बैलेंस की जांच करने के कई अन्य त्वरित तरीके हैं:

1. एसएमएस के जरिए

7738299899 पर एक एसएमएस भेजें।

“EPFOHO UAN ENG” टाइप करें, जहां “ENG” का मतलब अंग्रेजी है (आप हिंदी के लिए “HIN” या अपनी पसंदीदा भाषा के पहले तीन अक्षरों का भी उपयोग कर सकते हैं)।

आपको अपने नवीनतम पीएफ बैलेंस और खाते के विवरण के साथ एक एसएमएस प्राप्त होगा।

2. मिस्ड कॉल के जरिए

अपने पंजीकृत मोबाइल नंबर से 011-22901406 पर मिस्ड कॉल दें।

आपको अपने वर्तमान पीएफ बैलेंस के बारे में एक एसएमएस मिलेगा।

3. उमंग ऐप के जरिए

Google Play Store या Apple App Store से UMANG ऐप डाउनलोड करें।

“ईपीएफओ” अनुभाग पर जाएं और अपने यूएएन और अपने पंजीकृत मोबाइल पर भेजे गए ओटीपी का उपयोग करके लॉग इन करें।

शेष राशि और योगदान विवरण देखने के लिए अपनी पासबुक खोलें।

4. बिना यूएएन के

यदि आपके पास यूएएन नहीं है, तो भी आप अपने नियोक्ता के मानव संसाधन विभाग से संपर्क करके या अपने पीएफ खाता संख्या और आईडी प्रमाण के साथ निकटतम ईपीएफओ कार्यालय में जाकर अपना पीएफ बैलेंस देख सकते हैं।

अपने पीएफ बैलेंस की जांच करने का एक और आसान तरीका अपने नियोक्ता के मानव संसाधन या वित्त विभाग से संपर्क करना है।

अधिकांश कंपनियां कर्मचारियों को उनके पीएफ स्टेटमेंट तक नियमित पहुंच प्रदान करती हैं या अनुरोध पर उन्हें जेनरेट कर सकती हैं। नियोक्ताओं के पास ईपीएफओ पोर्टल तक पहुंच है, जो उन्हें आपके नवीनतम पीएफ बैलेंस विवरण को सीधे डाउनलोड करने और साझा करने की अनुमति देता है।

यदि आप अपने यूएएन सक्रियण या ऑनलाइन पहुंच में समस्याओं का सामना कर रहे हैं तो यह विधि विशेष रूप से उपयोगी है।

Source link

Household savings in equities and mutual funds jump nearly three-fold in three years

0

As of March 2025, equities and mutual funds together accounted for 15.2% of household savings—amounting to ₹5.4 lakh crore—up sharply from about ₹2 lakh crore in FY23. Direct equity exposure has also risen, with 2.1% of household savings now parked in stocks, compared with just 0.8% three years ago.

By Yoosef K October 3, 2025, 9:21:40 PM IST (Published)

2 Min Read

CNBCTV18 on Google
Household savings in equities and mutual funds jump nearly three-fold in three years
Indian households are steadily shifting away from traditional savings instruments such as bank deposits and life insurance toward market-linked products, with equities and mutual funds seeing a multi-fold jump in allocations over the past few years.

Continue Reading with
CNBC-TV18 Access Membership

Priority Access and Networking: CNBC-TV18’s flagship events

Interaction with CNBC-TV18’s journalists

Webinars & LIVE Q&As with India Inc. Leaders

Exclusive CNBC-TV18 studio & newsroom tours

Premium business insights, expert opinions & analysis

Curated lifestyle privileges & offers



Source link

India’s apex cotton body says prices at 4-year-low, industry’s survival vital to sustain cultivation

0

CMD of the Cotton Corporation of India, Lalit Kumar Gupta, has said that the survival of the textiles industry is necessary for farmers to sustain their interest in cotton cultivation, as he termed the interests of farmers and the industry interests as intertwined.President of the All India Cotton FPO Association, Manish Daga echoed the sentiment, terming Minimum Support Price (MSP) as the only lure in the market, adding that lack of access to MSP for farmers can lead to a decrease in cotton sowing area by as early as the next year.Stating that more exports will mean the industry will be able to afford to buy from cotton farmers, the Cotton Corporation’s CMD said that further decisions on extension of import duty waiver on cotton will be based on a “holistic approach”.

India has removed import duty on cotton till the end of the current calendar year. In view of global uncertainties, wars, and tariffs impacting textiles exports, he said that the government is taking all necessary steps to protect the interests of every stakeholder.As Gupta pointed to an 8% increase in the MSP for the current cotton season, he highlighted that cotton prices in domestic and global markets are at a 4-year low. He told CNBC-TV18 that the government has opened 550 procurement centres across 11 cotton-growing regions and improved access for farmers to market yards in the hope of crossing last year’s cotton procurement, which we described as the 2nd highest MSP operations.To align procurement with regional crop readiness, procurement operations have started in the Northern Zone (Punjab, Haryana, Rajasthan) from 1st October, and are slated to start in the Central Zone (Gujarat, Maharashtra, Madhya Pradesh, Odisha) from 15th October and the Southern Zone (Telangana, Andhra Pradesh, Karnataka, Tamil Nadu) from 21st October.Highlighting climate change, crop yields, and waterlogging as challenges for farmers as they may delay cotton flowering and compromise quality, Daga doesn’t expect any rise in price above MSP in the current calendar year as purchase of textiles is down. He said that farmers will stand to benefit if the Cotton Corporation of India purchases over 1.5 crore bales, like it did in previous years.However, he highlighted that procurement will be easier said than done and will depend on when it starts and the availability of quality cotton. Stating that India has 70-75% cotton farmers with small holdings, he added that they won’t be able to hold cotton till the new calendar year if it isn’t procured.

Source link

India, China lead global energy shift as renewables outpace coal for the first time in 2025

0

India contributed 5.6% of this growth, ranking among the top five countries after China, the US, and the EU. Here are the finer details of the landmark shift in ways countries around the world are meeting their electricity demand.

By CNBCTV18.com October 8, 2025, 9:36:25 PM IST (Published)
2 Min Read

CNBCTV18 on Google

Image count1 / 5
CNBCTV18 on Google

Renewable energy sources generated more electricity than coal globally for the first time in the first half of 2025, a development that some analysts called  “the first signs of a crucial turning point.” This shift is driven largely by China and India, according to a report by think tank Ember. (Image: Canva)

Image count2 / 5
CNBCTV18 on Google

India reduced coal and gas use by 3.1% while power generation from wind and solar energy increased remarkably by 29% and 31% respectively. On the contrary, fossil generation grew in Western countries like the US and the European Union (EU). (Image: Canva)

Image count3 / 5
CNBCTV18 on Google

Similarly, China, which is the world’s largest electricity consumer, reduced fossil-fuel generation by 2% while its solar and wind generation grew by 43% and 16% respectively, the report found. (Image: Canva)

Image count4 / 5
CNBCTV18 on Google

Małgorzata Wiatros-Motyka, ‍Senior Electricity Analyst, Ember said that the world is at the perfect time to embrace the economic, social and health benefits that come with increased solar, wind and batteries as costs of technologies continue to fall. “Solar and wind are now growing fast enough to meet the world’s growing appetite for electricity. This marks the beginning of a shift where clean power is keeping pace with demand growth,” she said. (Image: Canva)

Image count5 / 5
CNBCTV18 on Google

Solar power alone met 83% of the rise in global electricity demand in the first half of 2025 as global electricity demand grew by 2.6%. Solar power grew by a record 31% in the first half of 2025, lifting its share in global electricity from 6.9% to 8.8%. India contributed 5.6% of this growth, ranking among the top five countries after China, the US, and the EU. (Image: Canva)

Source link